Publikace
- HPLC determination of arginases inhibitor N-(omega)-hydroxy-nor-L-arginine using core-shell particle column and LC-MS/MS identification of principal metabolite in rat plasma2012 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome2019 | Farmaceutická fakulta v Hradci Králové
- The Importance of Wireless Capsule Endoscopy for Research into the Intestin Absorption Window of 5-Aminosalicylic Acid in Experimental Pigs2017 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- In vitro metabolism of fenofibric acid by carbonyl reducing enzymes2016 | Farmaceutická fakulta v Hradci Králové
- Novel Derivatives of Benfluron and Dimefluron: Synthesis and Anticancer activity2015 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Imaging and Evaluating Method as Part of Endoscopical Diagnostic Approaches2014 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats2014 | Farmaceutická fakulta v Hradci Králové
- Identification of combined conjugation of nabumetone phase I metabolites with glucuronic acid and glycine in minipig biotransformation using coupling high-performance liquid chromatography with electrospray ionization mass spectrometry2014 | Farmaceutická fakulta v Hradci Králové
- Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro2013 | Farmaceutická fakulta v Hradci Králové
- Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: Identification of new nabumetone metabolites2013 | Farmaceutická fakulta v Hradci Králové
Loading network view...